Literature DB >> 15798915

The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT--results of a randomized multicentre study.

Samuel Vokurka1, Eva Bystrická, Vladimír Koza, Jana Scudlová, Vladislava Pavlicová, Dana Valentová, Jana Bocková, Lubica Misaniová.   

Abstract

Antimicrobial solutions are widely used in the nursing care of chemotherapy induced oral mucositis (OM). There is little evidence, however, supporting their use for reducing mucosal damage. In our study, 132 patients were randomized to use normal saline (n=65) or povidone-iodine diluted 1:100 (n=67) mouthwashes for OM prophylaxis and treatment after high-dose chemotherapy comprising BEAM or HD-L-PAM followed by autologous peripheral stem cell transplantation. The study groups were well balanced in respect of age, sex, chemotherapy and the number of CD34+ cells in the graft. No significant difference was found between the groups in respect of OM characteristics, fever of unknown origin (FUO) and other infections. The antimicrobial solution was less tolerable for patients. OM occurred significantly more often in females than in males (86% vs 60%, P=0.0016) and was worse and of longer duration. The mechanical effect of mouthwashes might have a certain importance in FUO prevention. When indicating oral rinses, the patient's individual preference and tolerance of solutions offered should be considered.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15798915     DOI: 10.1007/s00520-005-0792-9

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  15 in total

1.  Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation.

Authors:  S T Sonis; G Oster; H Fuchs; L Bellm; W Z Bradford; J Edelsberg; V Hayden; J Eilers; J B Epstein; F G LeVeque; C Miller; D E Peterson; M M Schubert; F K Spijkervet; M Horowitz
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

2.  A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis.

Authors:  S H Okuno; R L Foote; C L Loprinzi; S Gulavita; J A Sloan; J Earle; P J Novotny; M Burk; A R Frank
Journal:  Cancer       Date:  1997-06-01       Impact factor: 6.860

Review 3.  Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis - are there new strategies?

Authors:  M Karthaus; C Rosenthal; A Ganser
Journal:  Bone Marrow Transplant       Date:  1999-11       Impact factor: 5.483

4.  Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy.

Authors:  R Rahn; I A Adamietz; H D Boettcher; V Schaefer; K Reimer; W Fleischer
Journal:  Dermatology       Date:  1997       Impact factor: 5.366

5.  Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study.

Authors:  O B Wijers; P C Levendag; E R Harms; A M Gan-Teng; P I Schmitz; W D Hendriks; E B Wilims; H van der Est; L L Visch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-06-01       Impact factor: 7.038

Review 6.  Antimicrobial therapy to prevent or treat oral mucositis.

Authors:  J Peter Donnelly; Lisa A Bellm; Joel B Epstein; Stephen T Sonis; R Paul Symonds
Journal:  Lancet Infect Dis       Date:  2003-07       Impact factor: 25.071

7.  Effects of benzydamine on the oral mucositis during antineoplastic radiotherapy and/or intra-arterial chemotherapy.

Authors:  A Prada; F Chiesa
Journal:  Int J Tissue React       Date:  1987

8.  Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy.

Authors:  M J Dodd; P J Larson; S L Dibble; C Miaskowski; D Greenspan; L MacPhail; W W Hauck; S M Paul; R Ignoffo; G Shiba
Journal:  Oncol Nurs Forum       Date:  1996-07       Impact factor: 2.172

9.  The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation.

Authors:  L P Samaranayake; A G Robertson; T W MacFarlane; I P Hunter; G MacFarlane; D S Soutar; M M Ferguson
Journal:  Clin Radiol       Date:  1988-05       Impact factor: 2.350

10.  Symptomatic acute mucositis can be minimized or prophylaxed by the combination of sucralfate and fluconazole.

Authors:  R R Allison; V Vongtama; J Vaughan; K H Shin
Journal:  Cancer Invest       Date:  1995       Impact factor: 2.176

View more
  16 in total

Review 1.  Interventions for preventing oral mucositis for patients with cancer receiving treatment.

Authors:  Helen V Worthington; Jan E Clarkson; Gemma Bryan; Susan Furness; Anne-Marie Glenny; Anne Littlewood; Martin G McCabe; Stefan Meyer; Tasneem Khalid
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

Review 2.  Systematic review of basic oral care for the management of oral mucositis in cancer patients.

Authors:  Deborah B McGuire; Janet S Fulton; Jumin Park; Carlton G Brown; M Elvira P Correa; June Eilers; Sharon Elad; Faith Gibson; Loree K Oberle-Edwards; Joanne Bowen; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2013-09-10       Impact factor: 3.603

Review 3.  Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis.

Authors:  Andrei Barasch; Sharon Elad; Arnold Altman; Kathryn Damato; Joel Epstein
Journal:  Support Care Cancer       Date:  2006-05-04       Impact factor: 3.603

4.  Higher incidence of chemotherapy induced oral mucositis in females: a supplement of multivariate analysis to a randomized multicentre study.

Authors:  Samuel Vokurka; Eva Bystrická; Vladimír Koza; Jana Scudlová; Vladislava Pavlicová; Dana Valentová; Maria Visokaiová; Lubica Misaniová
Journal:  Support Care Cancer       Date:  2006-02-25       Impact factor: 3.603

5.  Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines.

Authors:  Catherine H L Hong; Luiz Alcino Gueiros; Janet S Fulton; Karis Kin Fong Cheng; Abhishek Kandwal; Dimitra Galiti; Jane M Fall-Dickson; Jorgen Johansen; Suzanne Ameringer; Tomoko Kataoka; Dianna Weikel; June Eilers; Vinasha Ranna; Anusha Vaddi; Rajesh V Lalla; Paolo Bossi; Sharon Elad
Journal:  Support Care Cancer       Date:  2019-07-08       Impact factor: 3.603

Review 6.  Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients.

Authors:  Deborah P Saunders; Joel B Epstein; Sharon Elad; Justin Allemano; Paolo Bossi; Marianne D van de Wetering; Nikhil G Rao; Carin Potting; Karis K Cheng; Annette Freidank; Michael T Brennan; Joanne Bowen; Kristopher Dennis; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2013-07-06       Impact factor: 3.603

7.  Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study.

Authors:  Per Boye Hansen; Milena Penkowa
Journal:  Support Care Cancer       Date:  2016-12-13       Impact factor: 3.603

8.  Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation.

Authors:  Miroslaw Markiewicz; Monika Dzierzak-Mietla; Andrzej Frankiewicz; Patrycja Zielinska; Anna Koclega; Malgorzata Kruszelnicka; Slawomira Kyrcz-Krzemien
Journal:  Support Care Cancer       Date:  2012-06-27       Impact factor: 3.603

9.  Mineral derivatives in alleviating oral mucositis during cancer therapy: a systematic review.

Authors:  Sonia Lee
Journal:  PeerJ       Date:  2015-02-12       Impact factor: 2.984

Review 10.  Radiation-Induced Oral Mucositis.

Authors:  Osama Muhammad Maria; Nicoletta Eliopoulos; Thierry Muanza
Journal:  Front Oncol       Date:  2017-05-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.